NCT05587465 (LB2CT01) is a NA clinical trial of Lobster Device in Spinal Lumbar Stenosis, sponsored by Diametros Medical srl.

Who is sponsoring NCT05587465?

NCT05587465 is sponsored by Diametros Medical srl.

What drugs are being tested in NCT05587465?

Interventions in NCT05587465: Lobster Device.

What condition does NCT05587465 study?

NCT05587465 studies Spinal Lumbar Stenosis, Claudication, Intermittent.

Is NCT05587465 still recruiting?

NCT05587465 is currently status unknown. Last updated 24 October 2022.

Last reviewed 2022-10-24 · How we verify

NCT05587465: LB2CT01

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Safety and Effectiveness of Lobster Dynamic Interspinous Spacer in Lumbar Spinal Stenosis

Status unknown NA Last updated 24 October 2022

What this trial tests

NA trial testing Lobster Device in Spinal Lumbar Stenosis in 210 participants. Status unknown.

Timeline

5 October 2022

Primary endpoint
1 October 2024

1 October 2025

Quick facts

Lead sponsor	Diametros Medical srl
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	210
Start date	5 October 2022
Primary completion	1 October 2024
Estimated completion	1 October 2025
Sites	1 location across Italy

Drugs / interventions tested

Lobster Device

Conditions studied

Spinal Lumbar Stenosis — all drugs for Spinal Lumbar Stenosis →
Claudication, Intermittent — all drugs for Claudication, Intermittent →

Sponsor

Diametros Medical srl

Who can join

18 and older, any sex, with Spinal Lumbar Stenosis or Claudication, Intermittent. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to demonstrate the safety and effectiveness of the Lobster interspinous spacer device for the treatment of Lumbar Spinal Stenosis in comparison to an SSED-based performance goal.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05587465 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Diametros Medical srl
Last refreshed: 24 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05587465.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing